Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Overview of attention for article published in BMC Infectious Diseases, July 2005

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 23 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 33 publications that cite this research output.

33

The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.

Apples to Apples? A Comparison of Real-World Tolerability of Antiretrovirals in Patients with Human Immunodeficiency Virus Infection and Patients with Primary Biliary Cholangitis

Article in Viruses (March 2022)

Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study

Article in HIV/AIDS - Research and Palliative Care (March 2021)

Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia

Article in BMC Research Notes (October 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.